Physician profile
Michael Klein
NPI 1215222948
$17,155.27
in general payments reported to CMS, 2019-2025
10 companies · $7,556 in 2025
The $7,556 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.58 · 2022: $15.87 · 2023: $169 · 2024: $9,398 · 2025: $7,556.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $12K · Consulting Fee: $2,530 · Travel and Lodging: $2,003 · Food and Beverage: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $11,500.00 |
| Consulting Fee | $2,530.00 |
| Travel and Lodging | $2,002.65 |
| Food and Beverage | $1,090.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $16,559.81 | 2024-2025 | Cohealyx, Recell, Permeaderm |
| Polynovo North America LLC | $222.26 | 2023-2024 | Novosorb Btm |
| Zimmer Biomet Holdings, INC. | $84.75 | 2022-2025 | Ribfix Blu Advantage, Ribfix Titan |
| Atricure, INC. | $76.96 | 2023 | |
| Abbvie INC. | $52.89 | 2025 | |
| Smith+Nephew, INC. | $49.37 | 2024 | Grafix Pl |
| Solventum Corporation | $32.30 | 2025 | V.A.C.Ulta, Prevena, Activ.A.C. |
| Intuitive Surgical, INC. | $30.35 | 2025 | |
| Medtronic, INC. | $30.00 | 2025 | Eea |
| Acell, INC. | $16.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.